Insulin Pump Market Will Expand With MEMS Technology – Animas
This article was originally published in The Gray Sheet
Executive Summary
Animas aims to introduce a next-generation insulin micro-pump to the U.S. in 2007, having acquired rights to Debiotech's micro-electromechanical systems (MEMS) technology